RiverVest Venture Partners has more than doubled the capital raised for its last fund by pulling in over $167m towards its fourth flagship vehicle.
The St Louis-based firm bagged just over $80m for RiverVest Venture Fund III in 2015, and has obliterated that total with Fund IV to date according to a US SEC filing.
No further capital is to be raised for Fund IV according to the filing, although it does not say whether other capital from elsewhere will be invested with or its part of the fund.
The life sciences investment specialist, which was founded in 2000, has funded 39 companies in that time and sealed 20 exits.
It currently has about $340m of assets under management according to its website.
Earlier this month the firm led a $17m Series B financing round for medical device business Cardialen, which is developing a low-energy implantable defibrillation therapy designed to more gently restore normal heart rhythm.
Copyright © 2018 AltAssets